Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 5.90
+0.04 (0.68%)
May 27, 2026, 5:05 PM GMT
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 62.61 million as of May 27, 2026. Its market cap has increased by 140.41% in one year.
Market Cap
62.61M
Enterprise Value
76.37M
Revenue
36.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.90
Market Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 62.61M, a decrease of -63.12%. That is a compound annual growth rate of -9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 62.61M | -40.14% |
| Dec 31, 2025 | 104.59M | 395.31% |
| Dec 31, 2024 | 21.12M | -59.70% |
| Dec 29, 2023 | 52.40M | 186.53% |
| Dec 30, 2022 | 18.29M | -80.96% |
| Dec 31, 2021 | 96.06M | 28.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 30.29B |
| Hikma Pharmaceuticals | 3.18B |
| HUTCHMED (China) | 1.50B |
| Allergy Therapeutics | 576.26M |
| Venture Life Group | 68.83M |
| ECO Animal Health Group | 65.73M |
| Provexis | 25.80M |
| Chill Brands Group | 1.83M |